RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. PMV
P

PMV portfolio

PMV has 11 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 11.
Deals, last 12 months: 1.
Rounds led: 4 of 16.
Capital in their rounds: $398.72M.
Latest deal: Logibot · Sep 17, 2026.
About this page

It led 4 of the 16 rounds it joined. Its most recent investment on record is Logibot's $1.61M Seed round in September 2026, alongside BAN Flanders, RDY Ventures and Beam. By category, its portfolio leans toward Health and bio (7) and Robotics and hardware (3). It has co-invested with V-Bio Ventures, VIB and Qbic Fund, most often V-Bio Ventures (7 rounds).

What PMV invests in

PMV recent investments

CompanyRoundDateAlongside
LLogibotSeed · $1.61MBAN Flanders, RDY Ventures, Beam (lead)
AAzumutaSeries A · $9.27MAngelwise, Keen Venture Partners (lead), Capricorn Partners +1
AAspect AnalyticsSeries A · $11.73M · leadKU Leuven, HERAN Partners, Gemma Frisius Fund +1
AAnimabSeries B+ · $11.81M · leadQbic Fund (lead), Seventure Partners, Anacura +3
AAugustine TherapeuticsSeries A · $85MAsabys Partners, CMT Research Foundation, Newton Biocapital +6
NNobiSeries B+ · $37MAngelini Ventures (lead), EQT Health Economics, 15th Rock +5
AApideckSeries A · $7.5MAirbridge Equity Partners (lead)
CConfo TherapeuticsSeries B+ · $65MMINTS, Fund+, Wellington Management +7

How PMV invests

StageDealsCapital in rounds
Series A 8 50%$202.94M
Series B+ 5 31%$191.22M
Seed 3 19%$4.56M
YearDealsCapital in rounds
2016 1 6%$27M
2019 1 6%$34M
2020 2 13%$38.41M
2022 2 13%$49.27M
2023 1 6%$2.95M
2024 3 19%$90.67M
2025 5 31%$154.81M
2026 1 6%$1.61M

PMV portfolio companies

CompanyRound with PMVTotal raisedLatest raise
LLogibot
Robotics and hardware
Seed · $1.61M$1.61MSep 17, 2026
Seed
AAzumuta
AI agents
Series A · $9.27M$12.22MNov 13, 2025
Series A
AAspect Analytics
Voice and audio AI
Series A · $11.73M · lead$11.73MSep 9, 2025
Series A
AAnimab
Health and bio
Series B+ · $11.81M · lead$22.08MJul 1, 2025
Series B+
AAugustine Therapeutics
Health and bio
Series A · $85M$103.17MMar 24, 2025
Series A
NNobi
Health and bio
Series B+ · $37M$41MFeb 4, 2025
Series B+
AApideck
Fintech
Series A · $7.5M$7.5MDec 14, 2024
Series A
CConfo Therapeutics
Health and bio
Series B+ · $65M$99MAug 5, 2024
Series B+
EeTheRNA Immunotherapies
Health and bio
Series B+ · $39M$104.41MAug 24, 2022
Series B+
SSpectaCell
Health and bio
backer$6.72MOct 11, 2026
Seed
NNXGSAT
Robotics and hardware
backerundisclosedOct 21, 2025
Seed

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 16 rounds on Recent Funding that name PMV. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists PMV, which is a subset of its real portfolio. API: /api/v1/investors/pmv (get a free API key). More: the most active VC firms and new venture capital funds.